Structure and evolution of double minutes in diagnosis and relapse brain tumors

Ke Xu(St. Jude Children's Research Hospital), Liang Ding(St. Jude Children's Research Hospital), Ti‐Cheng Chang(St. Jude Children's Research Hospital), Ying Shao(St. Jude Children's Research Hospital), Jason Chiang(St. Jude Children's Research Hospital), Heather L. Mulder(St. Jude Children's Research Hospital), Shuoguo Wang(St. Jude Children's Research Hospital), Timothy I. Shaw(St. Jude Children's Research Hospital), Ji Wen(St. Jude Children's Research Hospital), Laura D. Hover(St. Jude Children's Research Hospital), Clay McLeod(St. Jude Children's Research Hospital), Yong‐Dong Wang(St. Jude Children's Research Hospital), John Easton(St. Jude Children's Research Hospital), Michael Rusch(St. Jude Children's Research Hospital), James Dalton(St. Jude Children's Research Hospital), James R. Downing(St. Jude Children's Research Hospital), David W. Ellison(St. Jude Children's Research Hospital), Jinghui Zhang(St. Jude Children's Research Hospital), Suzanne J. Baker(St. Jude Children's Research Hospital), Gang Wu(St. Jude Children's Research Hospital)
Acta Neuropathologica
September 28, 2018
Cited by 89Open Access
Full Text

Abstract

Double minute chromosomes are extrachromosomal circular DNA fragments frequently found in brain tumors. To understand their evolution, we characterized the double minutes in paired diagnosis and relapse tumors from a pediatric high-grade glioma and four adult glioblastoma patients. We determined the full structures of the major double minutes using a novel approach combining multiple types of supporting genomic evidence. Among the double minutes identified in the pediatric patient, only one carrying EGFR was maintained at high abundance in both samples, whereas two others were present in only trace amounts at diagnosis but abundant at relapse, and the rest were found either in the relapse sample only or in the diagnosis sample only. For the EGFR-carrying double minutes, we found a secondary somatic deletion in all copies at relapse, after erlotinib treatment. However, the somatic mutation was present at very low frequency at diagnosis, suggesting potential resistance to the EGFR inhibitor. This mutation caused an in-frame RNA transcript to skip exon 16, a novel transcript isoform absent in EST database, as well as about 700 RNA-seq of normal brains that we reviewed. We observed similar patterns involving longitudinal copy number shift of double minutes in another four pairs (diagnosis/relapse) of adult glioblastoma. Overall, in three of five paired tumor samples, we found that although the same oncogenes were amplified at diagnosis and relapse, they were amplified on different double minutes. Our results suggest that double minutes readily evolve, increasing tumor heterogeneity rapidly. Understanding patterns of double minute evolution can shed light on future therapeutic solutions to brain tumors carrying such variants.


Related Papers

No related papers found

Powered by citation graph analysis